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Abstract Intravascular ultrasound radiofrequency
(RF-IVUS)datapermittheanalysisofcoronaryplaque
composition in vivo and is used as an endpoint of
ongoing pharmacological intervention trials. We
assessed the reproducibility of volumetric RF-IVUS
analyses in mild-to-moderately diseased atheroscle-
rotic human coronary arteries in vivo. A total of 9,212
IVUS analyses on cross-sectional IVUS frames was
performed to evaluate the reproducibility of volumet-
ric RF-IVUS measurements in 33 coronary segments
with a length of 27 ± 7 mm. For vessel, lumen, and
plaque + media volume the relative measurement
differences (P = NS for all) were (A = intraobserver
comparison, same pullback) -0.40 ± 1.0%; -0.48 ±
1.4%; -0.35 ± 1.6%,(B = intraobserver comparison,
repeated pullback) -0.42 ± 1.2%; -0.52 ± 1.8%;
-0.43 ± 4.5% (C = interobserver comparison, same
pullback) 0.71 ± 1.8%; 0.71 ± 2.2%, and 0.89 ±
5.0%, respectively. For ﬁbrous, ﬁbro-lipidic, calcium,
and necrotic-core volumes the relative measurement
differences (P = NS for all) were (A) 0.45 ± 2.1%;
-1.12 ± 4.9%; -0.84 ± 2.1%; -0.22 ± 1.8%, (B)
1.40 ± 4.1%; 1.26 ± 6.7%; 2.66 ± 7.4%; 0.85 ±
4.4%, and (C) -1.60 ± 4.9%; 3.85 ± 8.2%; 1.66 ±
7.5%, and -1.58 ± 4.7%, respectively. Of note,
necrotic-core volume showed on average the lowest
measurement variability. Thus, in mild-to-moderate
atherosclerotic coronary artery disease the reproduc-
ibilityofvolumetriccompositionalRF-IVUSmeasure-
ments from the same pullback is relatively high, but
lower than the reproducibility of geometrical IVUS
measurements. Measurements from repeated pull-
backs and by different observers show acceptable
reproducibilities; the volumetric measurement of the
necrotic-core shows on average the highest reproduc-
ibility of the compositional RF-IVUS measurements
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Both, the progression of atherosclerotic plaque vol-
ume and unfavorable plaque tissue characteristics
contribute to the overall risk of cardiovascular events
[1–5]. Previous progression-regression studies with
intravascular ultrasound (IVUS) reported a certain
beneﬁcial effect of anti-atherosclerotic pharmacolog-
ical therapies on the progression of plaque volume;
however, this can only partly explain the clinical
beneﬁt observed [6–10]. While conventional grey-
scale IVUS permits accurate quantiﬁcation of plaque
and vessel dimensions, it has signiﬁcant limitations in
the assessment of plaque composition [6, 7, 11–15].
As a consequence, a spectral analysis of IVUS
radiofrequency (RF-IVUS) data has been developed
and is increasingly used in clinical research [16–22].
RF-IVUSquantiﬁescoronaryplaquecomponents(e.g.,
the necrotic core) with a high predictive accuracy, as
demonstrated in vitro and in vivo [23–25].
Volumetric RF-IVUS data may be interesting
endpoints of IVUS studies that evaluate anti-athero-
sclerotic pharmacological therapies [26]. However,
there is a lack of information on the reproducibility of
this approach [17]. Therefore, we assessed in athero-
sclerotichumancoronary segments thereproducibility
ofvolumetricRF-IVUSin vivobycomparinganalyses
from the same pullback, repeated pullbacks, and by
different observers.
Methods
Study population
To assess the reproducibility of segmental IVUS-RF
data analysis in mild-to-moderately diseased athero-
sclerotic human coronary arteries in vivo, we
repeatedly analyzed IVUS data sets of 33 at least
20 mm-long coronary segments from non-target and
non-treated coronary arteries with an angiographic
lumen diameter stenosis\50% and absence of severe
calciﬁcationorvesseltortuosity.TwomotorizedIVUS
pullbacks at a speed of 0.5 mm/s were available from
16patientsinregularsinusrhythminwhomclinically-
driven, elective diagnostic cardiac catheterizations
(n = 10) or percutaneous coronary interventions
(n = 6) required IVUS assessment. Informed consent
was obtained prior to cardiac catheterization from all
patients in accordance with the directives of the Local
Medical Ethics Committee.
RF-IVUS
Details regarding the RF-IVUS technique, also
known as virtual histology IVUS, and validation
have previously been described [16, 17, 23–25]. In
brief, spectral analysis of IVUS radiofrequency data
is used to create tissue maps in order to classify
atherosclerotic plaques into four major components
(ﬁbrous, ﬁbro-lipidic, calcium, and necrotic-core).
Different plaque components were represented
according to a dedicated color code (green, light-
green, white and red) (Fig. 1).
RF-IVUS acquisition
RF-IVUS data was acquired with commercially
available phased-array IVUS catheters (Eagle Eye
Gold 2.9F 20 MHz, Volcano Corporation, Rancho
Cordova, USA) by a dedicated RF-IVUS console
(Volcano Therapeutics, Rancho Cordova, USA). The
image acquisition was ECG-gated (Fig. 1). The
catheter probe was advanced C10 mm distal to the
most distal side-branch. Angiographic cine runs were
performed to deﬁne the position of the IVUS catheter.
After intracoronary injection of 200 lg nitroglycer-
ine, a continuous pullback of the IVUS catheter was
performed using a motorized pullback device at
0.5 mm/s (TrackBackII, Volcano Corporation, Ran-
cho Cordova, USA). In the patients of the present
study, a second pullback was performed using the
same IVUS catheter. Data of both pullbacks were
stored on hard disk.
RF-IVUS analysis
RF-IVUS analysis was performed off-line by two
experienced IVUS analysts (M.H., E.S.K.M.). The
ﬁrst pullback (I) was divided into segments as the
region of interest. Segments were located between
two adjacent side-branches and contained no major
calciﬁcation that could have limited quantitative
assessment of vessel cross-sectional area. Subse-
quently, the same segment was identiﬁed in the
second pullback (II) using side-by-side comparison of
longitudinal and cross-sectional views. In fact, this
approach was similar to the matching procedure as
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required for the matching procedure was recorded.
The vessel borders were traced using a semi-
automatic contour detection program (IVUSLab 4.4,
Volcano Corporation, Rancho Cordova, USA).
The borders of each cross-sectional image per
segment were manually corrected if required to meet
a high standard of accuracy. The lumen border was
detected by tracing the leading edge of the intima,
and the total vessel border by tracing the leading edge
of the adventitia. Plaque + media (total vessel -
lumen) was used as a measure of atherosclerotic
plaque [11, 12]. The time required for the correction
of the computerized contour detection was recorded.
For each coronary segment, the vessel geometrics
(lumen, total vessel and plaque + media volume) and
the volumetric compositional RF-IVUS (ﬁbrous,
ﬁbro-lipidic, calcium, and necrotic-core) were gen-
erated by applying Simpson’s rule (Fig. 1)[ 22, 27].
Volumetric plaque burden (%) was calculated as
[(plaque volume/total vessel volume) 9 100].
Each segment of the ﬁrst pullback (I) was analyzed
twice by the 1st observer (Ia and Ib) and once by the
2nd observer (Ic) after re-deﬁning the segments of
the ﬁrst pullback; the corresponding segment of the
second pullback (II) was analyzed once by the 1st
observer.
Data analysis
First, we compared repeated RF-IVUS measurements
(volumetric vessel geometrics and composition) from
Fig. 1 Image data acquisition and analysis. The R-wave peak
of the ECG triggered image acquisition during a motorized
pullback at a speed of 0.5 mm/s (A). Automated contour
detection of the luminal and vessel borders was performed on
all IVUS images acquired. A longitudinal reconstruction of the
segment was obtained from the entire three-dimensional
‘‘stack’’ of images (B). The direction of the longitudinal
reconstruction was indicated by an arrowhead on the cross-
sectional images. All contours were checked on the cross-
sectional frame and manual correction could be performed (C).
VH-IVUS analysis revealed (colour-encoded) information on
plaque composition from the space between the lumen and
vessel borders; volumetric data of the geometrical vessel
dimension and of plaque composition were automatically
generated for the segment (D)
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(intraobserver comparison, Ia versus Ib). Second,
we compared the RF-IVUS measurements from the
ﬁrst and second pullback analyzed by the 1st observer
(intraobserver comparison, Ia versus II). Third, we
compared RF-IVUS measurements from the ﬁrst
pullback between the 1st and 2nd observer (interob-
server comparison, Ia versus Ic).
Statistical analysis
Analyses were performed with SPSS 13.0 (SPSS Inc.,
Chicago, Illinois). Dichotomous data are presented as
frequencies. Quantitative data are presented as
mean ± 1 SD and compared using student t-test,
linear regression analysis, or ANOVA for repeated
measures with post hoc testing with Tukey honestly
signiﬁcant difference test. According to Bland and
Altman, the agreement between two measurements
were assessed by determining the mean ± 2S Do f
the between measurement differences [28]. A two-
sided P-value\0.05 was considered signiﬁcant.
Results
Study population
Thirty-three atherosclerotic coronary segments (six
proximal and six in the mid right, seven proximal and
six in the mid left anterior descending, ﬁve proximal
and three in the mid left circumﬂex coronary artery,
respectively) from 16 patients with stable angina (11
men, age 58 ± 8 years) were included. The heart rate
was 69 ± 14 bpm. There were no complications
related to the IVUS investigation.
RF-IVUS analysis and data
A total of 9,212 cross-sectional IVUS analyses were
performed (70 ± 21 frames/segment). Manual cor-
rection of the automatic border detection was required
in 96 ± 6% of frames/segment within 40 ± 11 min/
segment. Matching the segments of interest between
the repeated pullbacks I and II required 13 ± 5 min/
segment.
The length of the segments was 27 ± 7m m
(range: 20–46 mm) with a volumetric plaque burden
of 36 ± 8% (range: 23–55%). The atherosclerotic
segments contained pre-dominantly ﬁbrous (47%)
and necrotic-core (25%) tissue. Further data are
presented in Table 1.
Reproducibility of geometrical RF-IVUS
(intraobserver and interobserver comparison)
Data on the agreement and variability of repeated
geometrical RF-IVUS measurements (absolute and/or
relative differences) showed a high reproducibility
(Table 2 and Fig. 2). Repeated geometrical measure-
ments were highly correlated for intraobserver
comparison from the same pullback and repeated
pullbacks, and for the interobserver comparison
(r C 0.999, C 0.997, and C 0.995; P\0.001 for all;
data not shown).
The limits of agreement (i.e., 2 SD of mean
difference), which indicate the expected relative
difference between two measurements (Fig. 2), were
higher for two observers who analyzed the same
IVUS pullback than for the same observer who
analyzed repeated pullbacks, with signiﬁcantly lower
relative differences for total vessel and lumen volume
(P\0.01 for both, Table 2).
Reproducibility of compositional RF-IVUS
(intraobserver and interobserver comparison)
Data on the agreement and variability of repeated
compositional measurements (absolute and/or rela-
tive differences) as presented in Table 2 and Figs. 3
and 4 showed an acceptable reproducibility. Repeated
compositional measurements were highly correlated
for intraobserver comparison from the same pullback
and repeated pullbacks, and for the interobserver
comparison (r C 0.999, C 0.997, and C 0.995;
P\0.001 for all; data not shown). Of note, the
interobserver comparison of compositional RF-IVUS
measurements showed a higher variability than the
intraobserver comparison from repeated IVUS pull-
backs (Fig. 3) with signiﬁcantly higher relative
differences for ﬁbrous and ﬁbro-lipidic volume
(P\0.01 for both, Table 2).
Necrotic-core volume showed on average the
lowest measurement variability of all plaque compo-
nents in both, intraobserver and interobserver
comparisons.
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Why measure changes in plaque composition?
Serial IVUS has become an established imaging
method to measure effects of cardiovascular risk
factors and drugs on coronary plaque dimensions [6–
10, 29–31]. Plaque progression as measured by IVUS
may be linked to a signiﬁcant increase in risk of
clinical events as predicted by established risk-scores
[31]. Therefore, IVUS derived surrogate endpoints as
an alternative to clinical endpoints may expedite the
process of drug development and testing [6]. How-
ever, there is a contradiction between the signiﬁcant
clinical beneﬁt of certain pharmacological interven-
tions (e.g., statins) and the relatively small effect on
plaque volume, which may be explained by a
stabilizing effect on plaque composition [6, 7, 10,
26, 32].
Intravascular ultrasound radiofrequency analysis
RF-IVUS is an imaging technique that permits the
characterization and quantiﬁcation of plaque compo-
nents in vivo (16, 17, 23–25]. Non-serial studies
suggested a potential of RF-IVUS to detect high-risk
coronary plaques (i.e., thin-cap ﬁbroatheroma) and
offered new insights into coronary pathology [18–22].
Currently, large serial IVUS studies are on the way
that assess with a volumetric RF-IVUS approach
changes in plaque composition to analyze the effect of
atherosclerosis-modifying drugs on this new surrogate
endpoint [33].
Rationale for the present study and main ﬁndings
An important prerequisite for the use of RF-IVUS
data as an endpoint in serial studies is the assessment
of its reproducibility [17, 34]. Drug-induced effects
on coronary arterial dimensions and plaque compo-
sition may remain relatively small [7–10]. To date
there is a lack of volumetric reproducibility data
simulating a serial RF-IVUS study design (e.g.,
repeated pullbacks) [17, 34].
Therefore, we assessed in the present study the
reproducibility of repeated RF-IVUS analyses of
vessel geometrics and plaque composition in 33
coronary segments. The relative intraobserver differ-
ence of geometrical and compositional volumetric
analyses in repeated pullbacks was relatively low
(\0.6% for all geometric vessel volumes; \1% for
necrotic-core and\3% for ﬁbrous, ﬁbro-lipidic, and
calciﬁc plaque components) and showed good limits
of agreement. Of note, the interobserver comparison
of RF-IVUS of geometrical and compositional mea-
surements from the same pullback showed on average
Table 1 Volumetric RF-IVUS measurements of vessel geometrics and plaque composition of 1st and 2nd observer
1st Observer 2nd Observer
Pullback Ia Pullback Ib Pullback II Pullback Ic
Vessel geometrics
Total vessel volume (mm
3) 458.98 ± 118.1 460.24 ± 116.3 460.85 ± 118.1 456.27 ± 119.6
Lumen volume (mm
3) 290.05 ± 77.7 291.11 ± 76.8 291.33 ± 77.5 288.09 ± 77.9
Plaque + media volume (mm
3) 168.93 ± 70.4 169.12 ± 69.0 169.32 ± 70.3 168.17 ± 72.3
Plaque burden (%) 36.36 ± 8.3 36.33 ± 8.2 36.31 ± 8.2 36.34 ± 8.5
Plaque composition
Fibrous volume (mm
3) 34.06 ± 32.0 34.10 ± 32.0 33.68 ± 31.7 34.35 ± 32.1
Fibrous (%) 46.62 ± 15.5 46.44 ± 15.8 46.64 ± 15.8 46.98 ± 15.3
Fibro-lipidic volume (mm
3) 5.66 ± 7.7 5.70 ± 7.9 5.55 ± 7.5 5.49 ± 7.2
Fibro-lipidic (%) 6.94 ± 4.8 6.82 ± 4.7 6.93 ± 4.6 6.67 ± 4.8
Calcium volume (mm
3) 12.46 ± 9.5 12.48 ± 9.3 12.36 ± 9.5 12.48 ± 9.9
Calcium (%) 21.85 ± 11.7 21.98 ± 11.8 21.73 ± 11.8 21.40 ± 11.6
Necrotic-core volume (mm
3) 15.94 ± 13.5 16.00 ± 13.5 15.77 ± 13.1 16.15 ± 13.3
Necrotic-core (%) 24.59 ± 8.5 24.62 ± 8.7 24.70 ± 8.6 24.83 ± 8.7
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comparison of repeated pullbacks.
Reproducibility of IVUS measurements
The reproducibility of two-dimensional RF-IVUS
has been tested by Rodriguez-Granillo et al. who
compared repeated pullbacks from 16 coronary
lesions [34]. The relative intraobserver difference
was B3% for the cross-sectional area measurements
of vessel geometrics; in general compositional
measurements were more variable than geometrical
measurements. The relative intraobserver difference
was B6% for necrotic-core area, and 8–13% for
ﬁbrous, ﬁbro-lipidic, and calcium areas [34]. Never-
theless, a volumetric IVUS approach is likely to
result in a higher reproducibility. Kawasaki et al.
reported intra- and interobserver variabilities of
volumetric plaque compositional measurements
(\3.6% for both) from 20 lesions from the same
IVUS pullback by using the Integrated Backscatter
IVUS technique, which is based on a different
mathematical method compared to RF-IVUS by
Virtual Histology [17, 26].
Table 2 Intra- and interobserver measurement differences of volumetric vessel geometrics and plaque composition
Intraobserver
comparison
(same pullback)
Ia versus Ib
Intraobserver
comparison
(repeated
pullback)
Ia versus II
Interobserver
comparison
(same pullback)
Ia versus Ic
ANOVA PP 1 P2 P3
Vessel geometrics
DTotal vessel volume (mm
3) -1.25 ± 3.8* -1.67 ± 4.9* 2.72 ± 8.0* \0.01 NS \0.05 \0.01
% DTotal vessel volume (%) -0.40 ± 1.0 -0.42 ± 1.2 0.71 ± 1.8 \0.01 NS \0.01 \0.01
DLumen volume (mm
3) -1.06 ± 3.5* -1.28 ± 5.1* 1.95 ± 6.5* \0.05 NS NS \0.05
% DLumen volume (%) -0.48 ± 1.4 -0.52 ± 1.8 0.71 ± 2.2 \0.01 NS \0.05 \0.05
DPlaque + media volume (mm
3) -0.19 ± 2.9* -0.39 ± 5.8* 0.76 ± 7.5* 0.7 – – –
% DPlaque + media volume (%) -0.35 ± 1.6 -0.43 ± 4.5 0.89 ± 5.0 0.3 – – –
DPlaque burden (%) 0.03 ± 0.5* 0.05 ± 1.2* 0.02 ± 1.4* 0.9 – – –
% DPlaque burden (%) 0.04 ± 1.4 0.01 ± 3.7 0.20 ± 4.2 0.9 – – –
Plaque composition
DFibrous volume (mm
3) -0.04 ± 0.7* 0.38 ± 2.0* -0.28 ± 1.0* 0.1 – – –
% DFibrous volume (%) 0.45 ± 2.1 1.40 ± 4.1 -1.60 ± 4.9 \0.01 NS NS \0.01
DFibrous (%) 0.18 ± 0.6* -0.02 ± 1.2* -0.37 ± 1.5* 0.1 – – –
% DFibrous (%) 0.75 ± 1.7 0.24 ± 2.8 -1.00 ± 4.2 0.1 – – –
DFibro-lipidic volume (mm
3) -0.04 ± 0.3* 0.12 ± 0.5* 0.17 ± 0.8* 0.6 – – –
% DFibro-lipidic volume (%) -1.12 ± 4.9 1.26 ± 6.7 3.85 ± 8.2 \0.01 NS \0.01 \0.01
DFibro-lipidic (%) 0.11 ± 0.8* 0.00 ± 0.6* 0.27 ± 0.9* 0.6 – – –
% DFibro-lipidic (%) 0.27 ± 8.2 -0.07 ± 5.8 6.03 ± 9.1 \0.01 NS \0.05 \0.01
DCalcium volume (mm
3) -0.01 ± 0.3* 0.10 ± 0.8* -0.02 ± 1.0* 0.6 – – –
% DCalcium volume (%) -0.84 ± 2.1 2.66 ± 7.4 1.66 ± 7.5 0.1 – – –
DCalcium (%) -0.13 ± 0.4* 0.12 ± 1.3* 0.45 ± 1.5* 0.1 – – –
% DCalcium (%) -0.51 ± 1.7 1.52 ± 6.7 2.26 ± 6.9 0.1 – – –
DNecrotic-core volume (mm
3) -0.05 ± 0.4* 0.18 ± 0.8* -0.21 ± 0.8* 0.1 – – –
% DNecrotic-core volume (%) -0.22 ± 1.8 0.85 ± 4.4 -1.58 ± 4.7 0.1 – – –
DNecrotic-core (%) -0.03 ± 0.4* -0.11 ± 1.0* -0.23 ± 0.8* 0.9 – – –
% DNecrotic-core (%) 0.07 ± 1.8 -0.34 ± 3.6 -0.90 ± 3.4 0.4 – – –
P1 = Ia versus Ib vs. Ia versus II; P2 = Ia versus Ib vs. Ia versus Ic; and P3 = Ia versus II vs. Ia versus Ic. *Paired t-test Ia versus Ib;
Ia versus II; and Ia versus Ic P = NS for all. D = difference
Signiﬁcant P-values are represented in bold
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related to the variability of geometrical vessel analysis
[34, 35]. Tissue components mainly located in the
center of an atherosclerotic plaque may be less
sensitive to potential variation in border detection.
Factors of variability in geometrical vessel analyses in
a serial study design are—besides the quality of the
basic IVUS images—the quality of matching the
region of interest. Matching the cross-sectional target
slice from baseline and follow-up examination is
much more difﬁcult with a two-dimensional RF-IVUS
approach [11, 15]. The problem of matching has been
signiﬁcantly reduced by the use of volumetric IVUS,
which visualizes an entire coronary segment, permits
identiﬁcation of one or more landmarks (e.g., adjacent
side-branches), and is the current standard method in
serial IVUS trials that address atherosclerosis-modi-
fying strategies [7–10, 15].
In the present study, image acquisition was
performed in an ECG-gated fashion. ECG-gated
image acquisition prevents artifacts from cyclic
movement of the IVUS catheter and the systolic-
diastolic variation of the vessel dimensions which
results in a higher reproducibility of geometrical
IVUS measurements [13–15]. In agreement with our
results, Okkels et al. demonstrated a high reproduc-
ibility of vessel geometrical measurements from
repeated pullbacks using a dedicated ECG-gated
volumetric grey-scale IVUS technique [15].
The necrotic-core
Necrotic-core tissue is the characteristic feature of so-
called RF-IVUS derived thin-cap ﬁbroatheroma
(TCFA) [16–18]. Observational IVUS-RF studies
demonstrated an association between RF-IVUS
derived TCFA and both coronary and clinical insta-
bility [18, 19, 22]. RF-IVUS derived TCFA is
generally deﬁned as at least three consecutive two-
dimensional cross-sectional frames with C10%
Fig. 2 Agreement of repeated VH-IVUS measurements of geometrical vessel volumes. Bland–Altman plots of intra- (left, mid) and
interobserver (right) comparisons. D = difference
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tissueandaplaqueburdenareaofC40%[18].Because
of the two-dimensional nature of the deﬁnition of RF-
IVUS derived TCFA, serial assessment may be difﬁ-
cult as outlined above; this may result in a higher
measurementvariability.Besides,iftheluminalborder
is shared by thrombus—which is more likely in
coronary instability—the measurement variability of
plaque and lumen dimensions may be even higher, as
thrombus may be misclassiﬁed as ﬁbrous tissue [35].
A volumetric parameter that is less dependent on
matching problems is the RF-IVUS derived necrotic-
core volume. From a pathophysiological point of view
the necrotic core volume is a very interesting target, as
both the necrotic core size and its longitudinal extent
are related to the risk of plaque rupture that may
trigger cardiovascular events as demonstrated by
histopathological studies [4, 5, 36, 37]. In agreement
with these ﬁndings, Hong et al. recently found a
signiﬁcantly higher RF-IVUS derived necrotic-core
volume in lesions of patients with acute coronary
syndromes compared to patients with stable angina
[22]. In our study in patients with stable angina,
necrotic-core volume showed on average the highest
reproducibility of all plaque components. Based on
pathophysiological considerations and the favorable
measurement reproducibility, the parameter RF-IVUS
derived necrotic-core volume has the potential to
become a major imaging target of future pharmaco-
logical intervention trials with IVUS. Nevertheless,
the relation between serial changes of this parameter
and clinical endpoints has to be demonstrated.
Fig. 3 Agreement of repeated VH-IVUS measurements of compositional volumes. Bland–Altman plots of intra- (left, mid) and
interobserver (right) comparisons. D = difference
20 Int J Cardiovasc Imaging (2009) 25:13–23
123Limitations
To the best of our knowledge, this was the ﬁrst study
that tested the reproducibility of volumetric RF-
IVUS. The number of coronary segments was limited
but comparable to other studies that addressed the
reproducibility of IVUS measurements [13–15, 34,
38, 39]. All patients had stable angina pectoris.
Similar to other studies with IVUS and RF-IVUS, we
excluded tortuous and severely calciﬁed vessels
which could have led to non-uniform pullbacks
[34]. We analyzed high quality RF-IVUS image runs
with limited circumferential calciﬁcation which
resulted in a relatively high accuracy of total vessel
border detection [11, 12]. Therefore, measurement
reproducibility may be somewhat lower in routine
clinical IVUS cases; nevertheless, the selection
criteria of target segments in serial IVUS studies
are similar [7–10]. Inter-catheter and inter-system
variability was not addressed [34, 38, 39]. The high
accuracy of the off-line RF-IVUS analysis was
achieved at the expense of manual correction of the
automatically derived lumen and vessel contours;
accordingly, our data may not be generalized to on-
line application of RF-IVUS.
Conclusions
In mild-to-moderate atherosclerotic coronary artery
disease, the reproducibility of volumetric composi-
tionalRF-IVUSmeasurementsfromthesamepullback
is relatively high, but lower than the reproducibility of
geometricalIVUSmeasurements.Measurementsfrom
repeated pullbacks and by different observers show
acceptablereproducibilitiesfortheuseinaserialstudy
design; the volumetric measurement of the necrotic-
core shows on average the highest reproducibility of
the compositional RF-IVUS measurements.
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